The role of laparoscopy in the diagnosis and treatment of peritoneal carcinomatosis: A case report

Yale Journal of Biology and Medicine

Volumn 74, Issue 2, 2001, Pages 107-110

  Takizawa, Bayan T ^a,b   Shin, Eon K ^a   Masters, Louise ^a   Lancelle, Frederick ^a   Anaf, Vincent ^a   Shahabi, Shohreh ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CARCINOMATOSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DISEASE COURSE; FEMALE; HUMAN; LAPAROSCOPY; OVARY CARCINOMA; ULTRASOUND;

ANTINEOPLASTIC AGENTS; CARCINOMA; FEMALE; HUMANS; LAPAROSCOPY; MIDDLE AGED; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS;

EID: 0035000033     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rioux, M. and Michaud, C. Sonographic detection of peritoneal carcinomatosis: a prospective study of 37 cases. Abdom. Imaging 20:47-51, 1995.
2. Stenman, U.-H., Alfthan, H., Vartiainen, J., and Lehtovirta, P. Markers supplementing CA-125 in ovarian cancer. Ann. Med. 27:115-120, 1995.
3. Folk, J.J., Botsford, M., and Musa, A.G. Monitoring cancer antigen 125 levels in induction chemotherapy for epithelial ovarian carcinoma and predicting outcome on second-look procedure. Gynecol. Oncol. 57:178-182, 1995.
4. McGowan, L., Lesher, L.P., and Morris, H.J. Misstaging of ovarian cancer. Obstet. Gynecol. 65:568, 1985.
5. Young, R.C., Decker, D.G., and Wharton, J.T. Staging laparotomy in young early ovarian cancer. JAMA 250:3072, 1983.
6. Clough, K.B., Ladonne, J.M., Nos, C., Renolleau, C., Validire, P., and Durand, J.C. Second look for ovarian cancer: laparoscopy or laparotomy? A prospective study. Gynecol. Oncol. 72:411-417, 1999.
7. Skret, A., Kluza, R., and Fabisiak, W. The place of second-look laparoscopy in monitoring treatment of advanced malignant ovarian neoplasms. Ginekol. Pol. 68:193-198, 1997.
8. Green, T.H. Hemisulfur mustard in the palliation of patients with metastatic ovarian carcinoma. Obstet. Gynecol. 13:383, 1959.
9. Dunnick, N.R., Jones, R.B., and Doppren, J.L. Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics. AJR 133:221, 1979.
10. Jenkins, J., Sugarbaker, P.H., and Gianola, F.J. Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter. Surg. Gynecol. Obstet. 154:858, 1982.
11. Nelson, R.C., Chezmar, J.L., Hoel, M.J., Buck, D.R., and Sugarbaker, P.H. Peritoneal carcinomatosis: preoperative CT with intraperitoneal contrast material. Radiology 182:133-138, 1992.
12. Rustin, G.J., Gennigs, J.N., and Nelstrop, A.E. Use of CA-125 to predict survival of patients with ovarian carcinoma. J. Clin. Oncol. 7:1667, 1989.
13. Ron, I.-L., Inbar, M., Gelernter, I., Lewysohn, O., Ayalon, D., Dale, J., and Chaitchik, S. Use of CA 125 response to predict survival parameters of patients with advanced ovarian carcinoma. Acta Obstet. Gynecol. Scand. 73:658-662, 1994.